Remove 2016 Remove Drug Development Remove Molecular Biology Remove Pharma Companies
article thumbnail

Europe: Where is the drug discovery innovation?

Drug Discovery World

During the period 2016-2021, the Brazilian, Chinese and Indian markets grew by 11.7%, 6.7% Even before this, however, Amsterdam was established as an important centre for drug development. As companies move through the phases of development, they benefit from a long-established ecosystem of competency in clinical regulation.

Drugs 147
article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Jasmine has a background in neuroscience and genetic manipulation, with early works focused on using a combined structural and molecular biology approach to assess disease-associated proteins implicated in Alzheimer’s disease. big pharma or startups/spin off? Where do you enjoy more to work? What pro/cons?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What it takes to make cancer research more inclusive

Drug Discovery World

These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Instead, molecular markers are more accurate indicators of the patient’s associated risks. .

Research 130
article thumbnail

Scaling Phage Therapy

Codon

Because frankly, do you know of anything else that can work against multiple drug-resistant bacteria? ” A Global View Even as advances in computing and molecular biology usher in the era of a new, high-tech “phage therapy 2.0”,

Therapies 118